NCT07033819 Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib Status RECRUITING Phase PHASE2
NCT07031908 Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer Status NOT_YET_RECRUITING Phase N/A
NCT07030907 A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer Status RECRUITING Phase PHASE1
NCT07028229 Ultrasound Training Program for Gynecologic Cancer Staging in Residents Status NOT_YET_RECRUITING Phase NA
NCT07023627 A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression Status RECRUITING Phase PHASE2
NCT07023484 Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer Status RECRUITING Phase PHASE2
NCT07022535 Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer Status RECRUITING Phase PHASE2
NCT07000344 A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor Status TERMINATED Phase NA
NCT06999187 A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas Status RECRUITING Phase PHASE1
NCT06990516 SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06990503 SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT06977594 Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer Status NOT_YET_RECRUITING Phase NA
NCT06977334 IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy Detection Status COMPLETED Phase N/A
NCT06973161 ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors Status COMPLETED Phase N/A
NCT06958068 Sexual Health Integration in Treatment of Gynecological Oncology Status COMPLETED Phase N/A
NCT06954584 Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer Status RECRUITING Phase PHASE3
NCT06943521 A Study of MT-4561 in Patients With Various Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2